HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Prexasertib

HCID 46700756
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1234015-52-1
Standard SMILES
COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1
InChIKey
DOTGPNHGTYJDEP-UHFFFAOYSA-N
Molecular formula
C18H19N7O2
Average molar mass
365.4 g/mol
Monoisotopic mass
365.16002287

Overview

Prexasertib has been used in trials studying the treatment and basic science of mCRPC, Leukemia, Neoplasm, breast cancer, and Ovarian Cancer, among others.

Names & identifiers

Preferred name
Prexasertib
IUPAC
5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile
English name
LY 2606368
Molecular formula
C18H19N7O2
Molecular weight
365.39

Names & synonyms

Prexasertib1234015-52-1LY2606368LY-26063685-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)pyrazine-2-carbonitrile5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile820NH671E6DTXSID3010313265-[[5-[2-(3-Aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-2-pyrazinecarbonitrile5-({5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl}amino)pyrazine-2-carbonitrile2-Pyrazinecarbonitrile, 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)-2-Pyrazinecarbonitrile, 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-
Show more names
CS-1453LY 2606368Prexasertib free basePrexasertib (LY2606368)LY2606368 HCl(free base)LY 2606368
prexasertibum5-((5-(2-(3-Aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)-2-pyrazinecarbonitrileRefChem:868496ACR368ACR 368ACR-368DTXCID801516329Prexasertib [USAN]

Properties

Computed structural propertiesFilling in

XLogP
1.4
Topological polar surface area
135 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
8
Rotatable bonds
8
Heavy atoms
27
Formal charge
0
Complexity
499

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
608.5 · 608.5±55.0 °C(Predicted)
Density
1.37 · 1.37±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
insoluble in DMSO
form
A crystalline solid
pka
11.89 · 11.89±0.10(Predicted)
color
Light yellow to brown
InChI
InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)
InChIKey
DOTGPNHGTYJDEP-UHFFFAOYSA-N
SMILES
C1(C#N)=NC=C(NC2C=C(C3=C(OC)C=CC=C3OCCCN)NN=2)N=C1
FDA UNII
820 NH671E6 · 820NH671E6

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationAgents that inhibit PROTEIN KINASES.
Applications · 2 items

DescriptionLY2606368 is a checkpoint kinase 1 (Chk1) inhibitor with a Ki value of 0.9 nM against the purified target and IC50 values of In vitro, LY2606368 inhibits the doxorubicin-activated G2/M checkpoint in p53-deficient HeLa cells with an EC50 value of 9 nM. LY2606368, at 25 nM, also significantly induces apoptosis and inhibits colony formation in AGS and MKN1 gastric cancer cells.

UsesLY 2606368 is a novel CHK1 inhibitor under investigation as a chemopotentiating agent. It causes double-stranded DNA breakage while simultaneously removing the protection of the DNA damage checkpoints. LY 2606368 is representative of a novel class of drugs for the treatment of cancer and tumor growth inhibition.

Related reactions

2 records
New reaction record
HRID 185721 reaction equation
HRID 185721As productAs reactant
HRID 1878317 reaction equation
HRID 1878317As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1234015-52-1、1234015-54-3、1234015-57-6
PubChem CID
46700756
DTXSID
DTXSID301031326
ChEMBL
CHEMBL3544911
UNII
820NH671E6
Nikkaji
J3.517.082K
NCI Drug Dictionary
prexasertib
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338